A Community-Based Screening Program to Identify, Using Blood-Based Biomarkers, Individuals With or Without Alzheimer's Disease Symptoms Who Are at High Risk for Brain Amyloid Pathology
NCT06043700 · ACTIVE NOT RECRUITING · N/A
We track 1 ClinicalTrials.gov studies led by Eisai Limited. The portfolio skews toward N/A (1 trials).
1 clinical trials sponsored by Eisai Limited.
| Phase | Trials | Distribution |
|---|---|---|
| N/A | 1 | 100% |
Eisai Limited currently sponsors 1 clinical trials tracked on ReadTheTrial. These span N/A.
Eisai Limited conducts research across multiple therapeutic areas. Browse the trial listings for details.
Check the trial listings below for current recruitment status. Trial recruitment status can change frequently.